My Guess: Adam F. knew about the Regeneron halting many patients due to inefficiency, since Friday, and thought Leronlimab will be ineffective for the same reason.
He literally screwed many shorts, by not understand Leronlimab was not an IL6 thing per-se.
I feel bad for those shorts, as this should see $7 soon.
All IMO